Temporal lobe epilepsy surgery: Piriform cortex resection impacts seizure control in the long-term.
Journal
Annals of clinical and translational neurology
ISSN: 2328-9503
Titre abrégé: Ann Clin Transl Neurol
Pays: United States
ID NLM: 101623278
Informations de publication
Date de publication:
08 2022
08 2022
Historique:
revised:
19
06
2022
received:
28
03
2022
accepted:
20
06
2022
pubmed:
2
7
2022
medline:
18
8
2022
entrez:
1
7
2022
Statut:
ppublish
Résumé
Recently, we showed that resection of at least 27% of the temporal part of piriform cortex (PiC) strongly correlated with seizure freedom 1 year following selective amygdalo-hippocampectomy (tsSAHE) in patients with mesial temporal lobe epilepsy (mTLE). However, the impact of PiC resection on long-term seizure outcome following tsSAHE is currently unknown. The aim of this study was to evaluate the impact of PiC resection on long-term seizure outcome in patients with mTLE treated with tsSAHE. Between 2012 and 2017, 64 patients were included in the retrospective analysis. Long-term follow-up (FU) was defined as at least 2 years postoperatively. Seizure outcome was assessed according to the International League against Epilepsy (ILAE). The resected proportions of hippocampus, amygdala, and PiC were volumetrically assessed. The mean FU duration was 3.75 ± 1.61 years. Patients with ILAE class 1 revealed a significantly larger median proportion of resected PiC compared to patients with ILAE class 2-6 [46% (IQR 31-57) vs. 16% (IQR 6-38), p = 0.001]. Resected proportions of hippocampus and amygdala did not significantly differ for these groups. Among those patients with at least 27% resected proportion of PiC, there were significantly more patients with seizure freedom compared to the patients with <27% resected proportion of PiC (83% vs. 39%, p = 0.0007). Our results show a strong impact of the extent of PiC resection on long-term seizure outcome following tsSAHE in mTLE. The authors suggest the PiC to constitute a key target volume in tsSAHE to achieve seizure freedom in the long term.
Identifiants
pubmed: 35776784
doi: 10.1002/acn3.51620
pmc: PMC9380176
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1206-1211Informations de copyright
© 2022 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.
Références
J Neurosurg. 2018 Jul;129(1):174-181
pubmed: 29027855
Neuroimage Clin. 2013 Dec 14;4:190-200
pubmed: 24392306
J Neurosurg. 2010 Jan;112(1):168-85
pubmed: 19575575
Ann Clin Transl Neurol. 2021 Jan;8(1):177-189
pubmed: 33263942
JAMA. 2008 Dec 3;300(21):2548-50
pubmed: 19050199
J Neurooncol. 2019 Oct;145(1):143-150
pubmed: 31485921
JAMA Neurol. 2019 Jun 1;76(6):690-700
pubmed: 30855662
J Neurooncol. 2020 Sep;149(3):455-461
pubmed: 32990861
Front Neurol. 2021 Dec 09;12:777845
pubmed: 34956057
Lancet. 2011 Oct 15;378(9800):1388-95
pubmed: 22000136
JAMA. 2008 Dec 3;300(21):2497-505
pubmed: 19050193
Epilepsy Res. 2016 Sep;125:62-71
pubmed: 27394376
Epilepsia. 2019 Jun;60(6):1171-1183
pubmed: 31112302
J Neurooncol. 2021 Apr;152(2):339-346
pubmed: 33554293
Epilepsia. 2018 Mar;59(3):595-606
pubmed: 29392715
N Engl J Med. 2001 Aug 2;345(5):311-8
pubmed: 11484687
Epilepsia. 2022 Jan;63(1):176-189
pubmed: 34817885
Clin Neurol Neurosurg. 2021 Apr 20;205:106644
pubmed: 33962146
J Neurosurg. 2018 Jul 1;:1-8
pubmed: 29979119
Epilepsia. 2021 Oct;62(10):2344-2356
pubmed: 34338302